Drug intelligence / Profile preview

Glutaphos

Development stage
Unknown
Lead developer
Pascual Laboratories
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Administration
Oral
01

Overview

Glutaphos is an over-the-counter neurotonic supplement developed and marketed by Pascual Laboratories in the Philippines. It is formulated as a "brain vitamin" to enhance mental faculties such as memory, concentration, alertness, and productivity, particularly during periods of mental and physical fatigue. The product contains a combination of four active ingredients: glutamic acid (325 mg), dicalcium phosphate (200 mg), thiamine hydrochloride (Vitamin B1, 5 mg), and cyanocobalamin (Vitamin B12, 10 mcg). Glutamic acid serves as a precursor to the excitatory neurotransmitter glutamate, while the B-vitamins support nerve cell function, energy metabolism, and myelin maintenance. It is widely available in tablet form and is positioned for students and professionals seeking to optimize cognitive performance.

Brand names
Glutaphos
02

Targets

PDH (Pyruvate dehydrogenase complex)MTR (Methionine synthase)GluR (Glutamate receptors)

Beyond the preview

Go deeper on Glutaphos.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glutaphos.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call